Outcomes of Gleason Score ≤8 among High Risk Prostate Cancer Treated with (125)I Low Dose Rate Brachytherapy Based Multimodal Therapy

PURPOSE: To investigate the role of low dose rate (LDR) brachytherapy-based multimodal therapy in high-risk prostate cancer (PCa) and analyze its optimal indications. MATERIALS AND METHODS: We reviewed the records of 50 high-risk PCa patients [clinical stage ≥T2c, prostate-specific antigen (PSA) >...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Dong Soo, Gong, In Hyuck, Choi, Don Kyung, Hwang, Jin Ho, Shin, Hyun Soo, Oh, Jong Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743192/
https://www.ncbi.nlm.nih.gov/pubmed/23918571
http://dx.doi.org/10.3349/ymj.2013.54.5.1207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743192/
https://www.ncbi.nlm.nih.gov/pubmed/23918571
http://dx.doi.org/10.3349/ymj.2013.54.5.1207

Ejemplares similares